151. Rasmussen encephalitis
2 clinical trials,   4 drugs   (DrugBank: 2 drugs),   6 drug target genes,   84 drug target pathways
Searched query = "Rasmussen encephalitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04003922 (ClinicalTrials.gov) | October 1, 2019 | 20/6/2019 | Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term | Observational Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term | Rasmussen Encephalitis | Other: Adalimumab treatment | Assistance Publique Hopitaux De Marseille | NULL | Not yet recruiting | 2 Years | N/A | All | 40 | NULL |